Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome transmission fidelity protein 8 homolog (CHTF8) is a protein encoded by the CHTF8 gene in humans. CHTF8 is a component of the Ctf18-replication factor C (RFC) complex, which is required for sister chromatid cohesion and the fidelity of chromosome transmission during cell division. The CTF18-RFC complex participates in the ATP-dependent loading of proliferating cell nuclear antigen (PCNA) onto primed DNA, coordinating DNA replication and repair with chromatid cohesion. CHTF8 is expressed ubiquitously, with evidence of reduced expression in renal and prostate carcinomas. Although implicated in genomic stability and DNA replication, it is not formally validated as a direct therapeutic target in oncology or other disease areas.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome transmission fidelity protein 8 homolog (CHTF8).